|
Market Cap (20-May) $8,702,824,448 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $15.15 |
P/E 59.52 |
EPS 0.15 |
TLX released this announcement to the ASX on 25 May 2021, 8:40. The announcement is marked as price sensitive, and is 2 page(s) in length and 214.38kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.946% short sold according to ASIC data. It was ranked the 196th most shorted stock on the ASX. It is now ranked as the 53rd most shorted stock on the ASX with 4.757% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| TLX66 Meets Study Objectives in Patients with AL Amyloidosis | 25 May 2021, 8:40 |
| 1st Patient Dosed in Japanese Prostate Cancer Imaging Study | 25 May 2021, 8:22 |
| German Distribution Agreement with Eckert and Ziegler | 18 May 2021, 8:21 |
| App 3Y - issue of CEO options following Shareholder approval | 12 May 2021, 14:17 |
You must be logged in to post a reply.
Telix Pharmaceuticals 